PTEN has been considered an effective suppressor regulator of many cancers, including NSCLC, involved in the cell cycle, apoptosis, and tumour progression; it exerts a suppressive effect on tumours through the AKT pathway, by negatively regulating the intracellular levels of PI3K [78]. This evidence concerns the gene AKT1 and neoplasm.